Bioteque Corporation (TPEX:4107)
117.50
-0.50 (-0.42%)
At close: Mar 27, 2026
Bioteque Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,161 | 1,237 | 1,354 | 1,017 | 872.61 |
Short-Term Investments | 384.2 | 239.21 | 92.13 | 98.1 | 264.26 |
Trading Asset Securities | 122.08 | 120.28 | 118.59 | 151.56 | 146.97 |
Cash & Short-Term Investments | 1,667 | 1,596 | 1,565 | 1,267 | 1,284 |
Cash Growth | 4.42% | 2.04% | 23.49% | -1.31% | -11.89% |
Receivables | 322.5 | 268.13 | 259.16 | 290.93 | 287.42 |
Inventory | 294.36 | 320.7 | 294.64 | 331.71 | 314.91 |
Other Current Assets | 48.92 | 30.49 | 32.88 | 28.19 | 60.42 |
Total Current Assets | 2,333 | 2,216 | 2,151 | 1,918 | 1,947 |
Property, Plant & Equipment | 2,280 | 2,371 | 2,292 | 2,334 | 1,844 |
Long-Term Investments | 4.14 | 3.66 | 3.74 | 3.45 | 3.38 |
Long-Term Deferred Tax Assets | 3.67 | 3.69 | 6.52 | 2.77 | 3.34 |
Other Long-Term Assets | 39.26 | 51.3 | 166.83 | 222.63 | 63.61 |
Total Assets | 4,660 | 4,645 | 4,620 | 4,480 | 3,861 |
Accounts Payable | 106.71 | 114.84 | 137.01 | 135.49 | 159.01 |
Short-Term Debt | - | - | - | - | 27.67 |
Current Portion of Long-Term Debt | 143.14 | 149.8 | 147.46 | 34.11 | 15.37 |
Current Portion of Leases | 14.85 | 8.95 | 12.61 | 14.4 | 13.99 |
Current Income Taxes Payable | 66.89 | 78.65 | 61.82 | 75.09 | 55.04 |
Current Unearned Revenue | 47.75 | 57.54 | 38.08 | 44.97 | 28.13 |
Other Current Liabilities | 167.33 | 155.57 | 245.07 | 269.68 | 296.04 |
Total Current Liabilities | 546.67 | 565.35 | 642.06 | 573.73 | 595.25 |
Long-Term Debt | 153.29 | 296.43 | 446.23 | 523.08 | 105.3 |
Long-Term Leases | 286.1 | 285.45 | 288.23 | 300.84 | 309.22 |
Pension & Post-Retirement Benefits | 10.06 | 8.18 | 8.28 | 12.91 | 10.83 |
Long-Term Deferred Tax Liabilities | 56.71 | 49.04 | 45.45 | 37.94 | 37.07 |
Total Liabilities | 1,053 | 1,204 | 1,430 | 1,449 | 1,058 |
Common Stock | 692.98 | 692.98 | 692.98 | 692.98 | 692.98 |
Additional Paid-In Capital | 317.12 | 317.03 | 316.95 | 315.17 | 315.17 |
Retained Earnings | 2,578 | 2,386 | 2,170 | 2,025 | 1,846 |
Comprehensive Income & Other | 19.25 | 44.72 | 10.68 | -1.1 | -50.62 |
Shareholders' Equity | 3,607 | 3,441 | 3,190 | 3,032 | 2,803 |
Total Liabilities & Equity | 4,660 | 4,645 | 4,620 | 4,480 | 3,861 |
Total Debt | 597.38 | 740.63 | 894.53 | 872.43 | 471.55 |
Net Cash (Debt) | 1,070 | 855.82 | 670.01 | 394.53 | 812.29 |
Net Cash Growth | 24.97% | 27.73% | 69.82% | -51.43% | -27.54% |
Net Cash Per Share | 15.35 | 12.29 | 9.62 | 5.66 | 11.67 |
Filing Date Shares Outstanding | 69.3 | 69.3 | 69.3 | 69.3 | 69.3 |
Total Common Shares Outstanding | 69.3 | 69.3 | 69.3 | 69.3 | 69.3 |
Working Capital | 1,786 | 1,650 | 1,509 | 1,344 | 1,351 |
Book Value Per Share | 52.05 | 49.65 | 46.03 | 43.75 | 40.45 |
Tangible Book Value | 3,607 | 3,441 | 3,190 | 3,032 | 2,803 |
Tangible Book Value Per Share | 52.05 | 49.65 | 46.03 | 43.75 | 40.45 |
Land | 91.83 | 91.83 | 91.83 | 91.83 | 91.83 |
Buildings | 2,025 | 2,042 | 1,819 | 1,812 | 738.16 |
Machinery | 1,396 | 1,343 | 1,270 | 1,165 | 1,087 |
Construction In Progress | 1.28 | - | 57.98 | 59.78 | 592.48 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.